ROLE OF BIOCHEMICAL MARKERS IN THE MONITORING OF COVID-19 PATIENTS

dc.contributor.authorLetelier, Pablo
dc.contributor.authorEncina, Nicole
dc.contributor.authorMorales, Pablo
dc.contributor.authorRiffo, Alejandra
dc.contributor.authorSilva, Halett
dc.contributor.authorRiquelme, Ismael
dc.contributor.authorGuzman Oyarzo, Neftali
dc.date2021
dc.date.accessioned2021-04-30T17:07:22Z
dc.date.available2021-04-30T17:07:22Z
dc.description.abstractCOVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.
dc.identifier.citationJOURNAL OF MEDICAL BIOCHEMISTRY,Vol.40,115-128,2021
dc.identifier.doi10.5937/jomb0-29341
dc.identifier.urihttp://repositoriodigital.uct.cl/handle/10925/4137
dc.language.isoen
dc.publisherSOC MEDICAL BIOCHEMISTS SERBIA
dc.sourceJOURNAL OF MEDICAL BIOCHEMISTRY
dc.subject.englishcoronavirus disease
dc.subject.englishCOVID-19
dc.subject.englishSARS-CoV2
dc.subject.englishlaboratory diagnosis
dc.subject.englishbiomarkers
dc.titleROLE OF BIOCHEMICAL MARKERS IN THE MONITORING OF COVID-19 PATIENTS
dc.typeReview
uct.catalogadorWOS
uct.indizacionSCI
Files